Intracoronary adenosine administration in the right coronary artery: A word of caution

Emmanouil S. Brilakis; Subhash Banerjee

doi:10.1016/j.jcin.2011.11.008

Intracoronary adenosine administration in the right coronary artery: A word of caution

Emmanouil S. Brilakis, Subhash Banerjee

Risultato della ricerca: Contributo su rivista › Lettera › peer review

Lingua originale	Inglese
pagine (da-a)	245
Numero di pagine	1
Rivista	JACC: Cardiovascular Interventions
Volume	5
Numero di pubblicazione	2
DOI	https://doi.org/10.1016/j.jcin.2011.11.008
Stato di pubblicazione	Pubblicato - feb 2012
Pubblicato esternamente	Sì

Accesso al documento

10.1016/j.jcin.2011.11.008

Altri file e collegamenti

Link to publication in Scopus

Cita questo

@article{a3c354a9fffc48a0ad966971e13f5859,

title = "Intracoronary adenosine administration in the right coronary artery: A word of caution",

author = "Brilakis, {Emmanouil S.} and Subhash Banerjee",

note = "Funding Information: Please note: Dr. Brilakis received speaker honoraria from St. Jude Medical and Terumo; research support from Abbott Vascular and InfraRedx; and his spouse is an employee of Medtronic. Dr. Banerjee received speaker honoraria from St. Jude Medical, Medtronic, and Johnson & Johnson; and received research support from Boston Scientific and The Medicines Company. ",

year = "2012",

month = feb,

doi = "10.1016/j.jcin.2011.11.008",

language = "English",

volume = "5",

pages = "245",

journal = "JACC: Cardiovascular Interventions",

issn = "1936-8798",

publisher = "Elsevier Inc.",

number = "2",

}

TY - JOUR

T1 - Intracoronary adenosine administration in the right coronary artery

T2 - A word of caution

AU - Brilakis, Emmanouil S.

AU - Banerjee, Subhash

N1 - Funding Information: Please note: Dr. Brilakis received speaker honoraria from St. Jude Medical and Terumo; research support from Abbott Vascular and InfraRedx; and his spouse is an employee of Medtronic. Dr. Banerjee received speaker honoraria from St. Jude Medical, Medtronic, and Johnson & Johnson; and received research support from Boston Scientific and The Medicines Company.

PY - 2012/2

Y1 - 2012/2

UR - http://www.scopus.com/inward/record.url?scp=84857544100&partnerID=8YFLogxK

U2 - 10.1016/j.jcin.2011.11.008

DO - 10.1016/j.jcin.2011.11.008

M3 - Letter

SN - 1936-8798

VL - 5

SP - 245

JO - JACC: Cardiovascular Interventions

JF - JACC: Cardiovascular Interventions

IS - 2

ER -